- Record: found
- Abstract: found
- Article: not found
Autologous hematopoietic stem cell transplantation of patients with aggressive relapsing-remitting multiple sclerosis: Danish nation-wide experience.
Freja Jespersen
1 ,
Søren Lykke Petersen
2 ,
Pernille Andersen
3 ,
Finn Sellebjerg
4 ,
Melinda Magyari
4 ,
Per Soelberg Sørensen
4 ,
Morten Blinkenberg
4
Aug 2023
Read this article at
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Autologous hematopoietic stem cell treatment (AHSCT) is considered an effective treatment option for patients with aggressive relapsing-remitting multiple sclerosis (RRMS). Still there are few randomized and controlled studies of AHSCT to shed light on the safety and efficacy of the treatment, and therefore experiences from single centers are important.